Fact CheckerSign in

NCT04655092RecruitingPhase 3

Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients

Extension Study of P1101 in Japanese Patients Who Have Completed Phase 2 Single Arm Study in Polycythemia Vera (PV) Patients (Study A19-201) or Phase 3 Study in Essential Thrombocythemia (ET) Patients (Study P1101 ET)

Source: ClinicalTrials.gov · Last updated 8 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This is a Phase 3 open-label, multicenter, single arm study designed to evaluate the efficacy and safety and tolerability of P1101 patient with PV or ET in long-term.

Status (registry)
Recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
67 (estimated)
First submitted
18 Nov 2020
Start date
Jan 2021
Primary completion date
Jun 2026
Lead sponsor
PharmaEssentia Japan K.K.
NCT number
NCT04655092

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 67
  • From Jan 2021 to the primary completion date, Jun 2026
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who are considered by the investigator or sub investigator to be ineligible for continued treatment with P1101

Who the study is looking for

  • Patients who have completed the 52-week treatment duration in Study A19-201 and are considered by the investigator or sub investigator to be eligible for participation in this study
  • Patients who have given written informed consent to participate in this study

Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Juntendo University Hospital
Coordinator of this site? Confirm its status
Bunkyo-kuJapanRecruiting
University of Yamanashi Hospital
Coordinator of this site? Confirm its status
Chuo-shiJapanRecruiting
Tokyo Medical University Hospital
Coordinator of this site? Confirm its status
Shinjuku-kuJapanRecruiting
Osaka University Hospital
Coordinator of this site? Confirm its status
Suita-shiJapanRecruiting
Ehime University Hospital
Coordinator of this site? Confirm its status
Toon-shiJapanRecruiting
Mie University Hospital
Coordinator of this site? Confirm its status
TsuJapanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.